Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials.
- Citation:
- J Clin Oncol vol 26 (4) 527-34
- Year:
- 2008
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- UL1 TR000005
- Corr. Author:
- Authors:
- Edward L Korn Ping-Yu Liu Sandra J Lee Judith-Anne W Chapman Donna Niedzwiecki Vera J Suman James Moon Vernon K Sondak Michael B Atkins Elizabeth A Eisenhauer Wendy Parulekar Svetomir N Markovic Scott Saxman John M Kirkwood
- Networks:
- Study
- NCCTG-N9975
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Benchmarking, Brain Neoplasms, Clinical Trials, Phase II as Topic, Disease-Free Survival, Humans, Melanoma, Meta-Analysis as Topic, Multivariate Analysis, Prognosis, Research Design, Sample Size, Skin Neoplasms, Survival Analysis, Survival Rate